Assessment of an Extracorporeal Liver Assist Device in Anhepatic Dogs
- 1 August 1992
- journal article
- Published by Wiley in Artificial Organs
- Vol. 16 (4), 418-422
- https://doi.org/10.1111/j.1525-1594.1992.tb00543.x
Abstract
We have used an anhepatic dog model to demonstrate the efficacy of a bioartificial liver assist device. Six dogs underwent total hepatectomy. Three received only medical care (controls) while the remainder were connected to an extracorporeal liver assist device (ELAD). The control dogs failed to regain consciousness after anesthesia although all lived 4–5 h postoperativlely. Plasma ammonia concentration increased by an average of 2–50 μmol/L between the end of surgery and the demise of the animals. The treated dogs lived 3–12.5 h, and 2 of them required repeated doses of thiamylal sodium to maintain sedation. Plasma ammonia concentration was unchanged after connection to the ELAD except in the longest survivor, whose ammonia began to rise after 8 h on the ELAD. The short survival in the other 2 treated dogs was the result of uncontrolled intraabdominal bleeding. This device is capable of replacing the metabolic function of the liver, and might provide hepatic support in patients awaiting transplantation or in fulrninant hepatic failure.Keywords
This publication has 11 references indexed in Scilit:
- Reversal of fulminant hepatic failure using an extracorporeal liver assist deviceHepatology, 1992
- One-stage hepatectomy in the dogJournal of Surgical Research, 1990
- Artificial Liver for a Bridge to Liver TransplantationArtificial Organs, 1989
- Fulminant Hepatic Failure and the Need for Artificial Liver SupportMayo Clinic Proceedings, 1988
- Postdilution Hemofiltration in the Management of Acute Hepatic Failure: A Pilot StudyMayo Clinic Proceedings, 1988
- Hepatic assist device, using membrane plasma separator and dialyzerPublished by Springer Nature ,1987
- Experimental Artificial Liver Support with Emphasis on Fulminant Hepatic Failure: Concepts and ReviewSeminars in Liver Disease, 1986
- Clinical Experience with Charcoal and Resin HemoperfusionSeminars in Liver Disease, 1986
- EARLIER CHARCOAL HAEMOPERFUSION IN FULMINANT HEPATIC FAILUREThe Lancet, 1982
- CHARCOAL HÆMOPERFUSION IN THE TREATMENT OF FULMINANT HEPATIC FAILUREThe Lancet, 1974